Following on from part one, in this webinar Mathys & Squire attorneys Peter Arch and Alexander Robinson take a closer look at controversies arising from recent case law, including whether SPCs can be granted for second medical indications, and how precisely the authorised product must be identified in a patent before being eligible for an SPC.